ThinkGenetic announces that Chief Genetic Officer, Dawn Laney, MS, CGC, CCRC, will be participating in a 19th Annual WORLDSymposium™ Satellite Symposia entitled “Understanding Phenotypic Variability in Lysosomal Diseases – Gaining a Foothold in Precision Medicine” sponsored by Takeda Pharmaceutical Company Limited. The WORLDSymposium™ is an annual research conference dedicated to lysosomal diseases and will be taking place in Orlando, Florida February 22 – 26, 2023.
This symposium is designed for basic, translational, and clinical researchers, patient advocacy groups, clinicians, and all others who are interested in learning more about the latest discoveries related to lysosomal diseases and the clinical investigation of these advances. The session will be a LIVE in-person gathering in Orlando at the Hilton Orlando Hotel. In addition, plans are also underway to make the program available ON DEMAND after the conference ends to allow for registration for those who are unable to attend in person.”
Other ThinkGenetic team members in attendance at WORLD will include:
Members of the leadership team continue to participate in this annual event for its important research presentations and to meet with key decision-makers to discuss potential partnership opportunities.
Interested in scheduling a meeting with ThinkGenetic at the WORLDSymposium?
Panel Presentation at Satellite Symposia
Date and Time: Thursday, February 23, 2023, 5:15 PM – 6:15 PM EST
Title: Understanding Phenotypic Variability in Lysosomal Diseases – Gaining a Foothold in Precision Medicine
Panel includes:
- Dawn Laney, MS, CGC, CCRC – Emory University School of Medicine
- Charlotte Hobbs, MD, PhD – Rady Children’s Institute for Genomic Medicine
- Melissa Wasserstein, MD – The Children’s Hospital at Montefiore and the Albert Einstein College of Medicine
Sponsor: Takeda Pharmaceutical Company Limited
Takeda approved the release of this communication on 2023-Feb-08.
